GOBIVAZ 100 mg solution for injection in pre-filled syringe
*Company:
ADVANZ PharmaStatus:
UpdatedLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 20 July 2026
File name
PIL - Clean - PFS 100 mg.pdf
Reasons for updating
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - excipient warnings
- Change to section 3 - how to take/use
- Change to section 5 - how to store or dispose
- Change to section 6 - what the product contains
- Change to section 7 - Instructions for use
Updated on 20 July 2026
File name
SPC - Clean - PFS 100 mg.pdf
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 6.1 - List of excipients
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 8 - Marketing authorisation number(s)
Legal category:Product subject to restricted prescription (C)
File name
AW-MG-0000045 (syringe).pdf
Reasons for updating
- Replace File
File name
Gobivaz-Patient Reminder Card.pdf
Reasons for updating
- Add New Doc
Updated on 26 November 2025
File name
GOBIVAZ 100 mg solution for injection in pre-filled syringe_PIL.pdf
Reasons for updating
- New PIL for new product
Updated on 26 November 2025
File name
GOBIVAZ 100 mg PEN & PFS_SPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
ADVANZ Pharma
Address:
Unit 17 Northwood House Northwood Crescent Northwood, Dublin 9, D09 V504, IrelandMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230